(CercleFinance.com) – GeNeuro announces the appointment of Anke Post as chief medical officer, effective last Friday, following the retirement of David Leppert, who had held this position since April 2020.
After his retirement, David Leppert will, however, continue, as a consultant, to support the biopharmaceutical company in its mission to introduce temelimab to patients with multiple sclerosis.
Anke Post brings to GeNeuro her experience in neuroscience, psychiatry and neurology, as well as the pharmaceutical industry. She has held senior management positions including Novartis, Eli Lilly and Roche.